December 17, 2025
4:23 pm
Xcelerating the growth, success and full potential of MedTech development and Healthcare Delivery with End to End control.
Xcelerate seeks to acquire rather than develop its technology / healthcare delivery. We understand that engineering advancements in non-medical fields often have unrealized applications in medical technology & clinical care and the silos existing between advanced engineering and medicine have been poorly bridged. Xcelerate is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and its application to clinical care.
At Xcelerate, we bridge the gap between advanced engineering and clinical care. We identify breakthrough innovations – often from non-medical fields – and unlock their potential in healthcare.
By pairing engineering advancements with early-stage med tech companies and applying them within controlled clinical settings, we accelerate development, reduce costs, and bring impactful medical technologies to market faster.
Xcelerate’s mission is to advance healthcare by transforming breakthrough engineering innovations into impactful medical technologies. Through strategic patent acquisition, focused Research & Development, and accelerated medtech development — including emerging telehealth solutions — we bridge the gap between engineering and clinical care. By integrating clinical insight with technical innovation, we reduce development risk, shorten time to market, and deliver meaningful medical progress with sustainable returns.
To become the leading bridge between breakthrough engineering and clinical care — accelerating medtech innovation from concept to real-world application. We envision a future where advanced medical technologies are not only developed faster and more efficiently, but are made accessible to all patients, including underserved and economically disadvantaged communities. By lowering development barriers and improving affordability, we aim to expand access to high-quality care and help close the gap between innovation and those who need it most.
Governance & Leadership
Xcelerate is led by a distinguished team of executive Directors, clinicians, scientists, and advisors with deep expertise across forensic finance, healthcare innovation, scientific research, global business development, and securities law. From Nobel Prize–recognized medical discovery to hands-on medtech commercialization and strategic capital markets guidance, our leadership brings the experience, credibility, and vision required to bridge engineering breakthroughs with real-world clinical impact.
Strategic oversight and disciplined governance guiding long-term value creation.
Experienced leadership ensuring financial integrity and institutional accountability.
World-class medical and research expertise driving innovation and clinical translation.
Proven commercialization insight bridging breakthrough science with real-world care.
Disciplined scientific evaluation and technical advancement driving scalable medtech innovation.
Focused development strategy accelerating the translation of patents into clinically validated solutions.
Structured regulatory oversight and securities compliance for disciplined expansion.
Experienced legal guidance supporting capital markets strategy and corporate governance.
$XCRT Tanzania has officially launched Universal Health Insurance (UHI) as of Jan 26, 2026. This mandatory scheme ensures health coverage for all citizens.
Telemedicine is a central pillar of Tanzania’s strategy to achieve universal healthcare.
https://presswire.com/release/tanzania-launches-universal-health-insurance-joining-africas-drive-for-inclusive-care/
